SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Perez Javier)
 

Search: WFRF:(Perez Javier) > (2015-2019) > Effects of Estrogen...

Effects of Estrogen and Phytoestrogen Treatment on an In Vitro Model of Recurrent Stroke on HT22 Neuronal Cell Line

Morán, Javier, 1986 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap,Institute of Neuroscience and Physiology, Department of Clinical Neuroscience
Perez-Basterrechea, M. (author)
Garrido, P. (author)
show more...
Diaz, E. (author)
Alonso, A. (author)
Otero, J. (author)
Colado, E. (author)
Gonzalez, C. (author)
show less...
 (creator_code:org_t)
2016-04-08
2017
English.
In: Cellular and Molecular Neurobiology. - : Springer Science and Business Media LLC. - 0272-4340 .- 1573-6830. ; 37:3, s. 405-416
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • An increase of stroke incidence occurs in women with the decline of estrogen levels following menopause. This ischemic damage may recur, especially soon after the first insult has occurred. We evaluated the effects of estrogen and phytoestrogen treatment on an in vitro recurrent stroke model using the HT22 neuronal cell line. HT22 cells were treated with 17 beta-estradiol or genistein 1 h after the beginning of the first of two oxygen and glucose deprivation/reoxygenation (OGD/R) cycles. During the second OGD, there was a deterioration of some components of the electron transport chain, such as cytochrome c oxidase subunit 1 with a subsequent increase of reactive oxygen species (ROS) production. Accordingly, there was also an increase of apoptotic phenomena demonstrated by poly(ADP-ribose) polymerase 1 cleavage, Caspase-3 activity, and Annexin V levels. The recurrent ischemic injury also raised the hypoxia-inducible factor 1 alpha and glucose transporter 1 levels, as well as the ratio between the lipidated and cytosolic forms of microtubule-associated protein 1A/1B-light chain 3 (LC3-II/LC3-I). We found a positive effect of estradiol and genistein treatment by partially preserving the impaired cell viability after the recurrent ischemic injury; however, this positive effect does not seem to be mediated neither by blocking apoptosis processes nor by decreasing ROS production. This work contribute to the better understanding of the molecular mechanisms triggered by recurrent ischemic damage in neuronal cells and, therefore, could help with the development of an effective treatment to minimize the consequences of this pathology.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Keyword

Recurrent stroke
Genistein
17 beta-estradiol
Apoptosis
Oxidative metabolism
HT22 cells
hypoxia-inducible factor
hormone replacement therapy
transient
global-ischemia
focal cerebral-ischemia
nitric-oxide
mitochondrial
biogenesis
glucose-transporter
induced apoptosis
cortical-neurons
rat hippocampus
Cell Biology
Neurosciences & Neurology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view